Jodi Ball, MD
Obstetrics & Gynecology · Kenmore, NYNPI 1578881058
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,639 of the $4,107 with a category attached, or 88.6%. It is spread thinly across 32 manufacturers, the largest accounting for just 10.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $945 and has fallen 57.9% since, to $398 in 2025. Among obstetrics & gynecology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 214 payments — averaging $19.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$443
- Therapeuticsmd, Inc.$441
- Exeltis, USA Inc.$338
- Novo Nordisk$269
- Avion Pharmaceuticals$257
- Amgen$211
- plus $2K from 26 others
What the payments were for
- Food & beverage$3,63989%
- Education$46711%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 10 | $443 |
| Therapeuticsmd, Inc. | 30 | $441 |
| Exeltis, USA Inc. | 18 | $338 |
| Novo Nordisk | 14 | $269 |
| Avion Pharmaceuticals | 17 | $257 |
| Amgen | 13 | $211 |
| Mayne Pharma Commercial LLC | 9 | $211 |
| Shield Therapeutics Inc | 11 | $206 |
| Millicent US Inc | 8 | $196 |
| Pfizer | 10 | $167 |
| AbbVie(2 entities) | 9 | $160 |
| Coopersurgical, Inc. | 7 | $136 |
| Bayer | 7 | $121 |
| Organon | 6 | $113 |
| Scynexis, Inc. | 6 | $101 |
| Agile Therapeutics, Inc. | 5 | $100 |
| AMAG Pharmaceuticals, Inc. | 7 | $91 |
| Daiichi Sankyo Inc. | 3 | $73 |
| Merck | 4 | $73 |
| Mylan Pharmaceuticals Inc. | 4 | $65 |
| Biogen | 2 | $53 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| Hologic Sales And Service, LLC | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Gilead | 1 | $28 |
| Medtronic | 1 | $24 |
| Evofem Biosciences, Inc. | 1 | $22 |
| Roche Diagnostics Corporation | 1 | $21 |
| Duchesnay USA Incorporated | 1 | $17 |
| Smith+Nephew | 1 | $16 |
| Mission Pharmacal Company | 1 | $16 |
| Cosette Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,107 in reported general payments places this provider in the 90th percentile of 2,673 obstetrics & gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 16 | $646 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Kenmore
- Mary PolanNew York$862K
- Steven GoldsteinNew York$551K
- Veronica LernerNew York$368K
- Lisa EngNew York$219K
- Theodore GoldmanEast Northport$213K
- Miriam CremerBrooklyn$196K
- Rachel MaschNew York$187K
- Amy PollackNew York$184K
- Jian Qun HuangNew York$160K
- Carolyn WesthoffNew York$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.